As expected, TNBC patients were more likely to be younger (p = 0.030), black (p<0.001), have ductal histology (p<0.001), and higher grade tumors (p<0.001) than patients with ER+ breast cancer despite the higher proportion of advanced stages in the ER+ patients due to the sampling method. The gene discussed is ESR1; the disease is breast carcinoma.